Neoplasia outcomes following colonoscopy for Lynch syndrome at a dedicated center vs. community centers

Abstract

Background and study aims

The European Society for Gastrointestinal Endoscopy recommends Lynch syndrome patients be followed in centers that monitor compliance and measure endoscopic performance. It is unclear if this policy impacts neoplasia outcomes. We investigated whether neoplasia outcomes were better at a dedicated center vs. community-based endoscopy centers.

Patients and methods

We reviewed findings of surveillance colonoscopy in 129 Lynch patients according to whether the previous colonoscopy was performed at a community vs. dedicated center and compared detection rates of advanced lesions (cancers plus advanced precancerous lesions) at colonoscopy.

Results

There were five cancers identified at a surveillance colonoscopy: one after a colonoscopy at the dedicated center at an interval of 137 months and four after community center colonoscopies at intervals of 12, 14, 26, and 77 months. Detection of advanced lesions (cancer plus advanced precancerous lesions) was higher after colonoscopy performed at community centers compared with the dedicated center (12.0% vs 4.1%; odds ratio [OR] 3.20; 95% confidence interval [CI] 1.30–7.90). The cancer detection rate after previous colonoscopy at community centers was 4.3%, compared with 0.4% after colonoscopy at the dedicated center (OR 12.23; 95% CI 1.4–107.2). The interval between previous and surveillance colonoscopy was longer if the previous colonoscopy was performed at a community center (934 +/- 1037 days vs. 589 +/- 445 days; P = 0.006).

Conclusions

A dedicated center with consistently high colonoscopy performance measures and navigation to augment patient adherence provided superior neoplasia outcomes in Lynch syndrome patients compared with community colonoscopy centers.

Keywords

Endoscopy Lower GI Tract - Colorectal cancer - Polyps / adenomas / ... - Quality and logistical aspects - Lynch Syndrome

Publication History

Received: 12 June 2025

Accepted after revision: 05 January 2026

Accepted Manuscript online:
20 January 2026

Article published online:
10 February 2026

• References

• 1 Giardiello FM, Allen JI, Axilbund JE. et al. Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the U.S. Multi-Society Task Force on Colorectal Cancer. Gastrointest Endosc 2014; 80: 197-220
• 2 van Leerdam ME, Roos VH, van Hooft JE. et al. Endoscopic management of Lynch syndrome and of familial risk of colorectal cancer: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2019; 51: 1082-1093
• 3 Monahan KJ, Bradshaw N, Dolwani S. et al. Guidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)/Association of Coloproctology of Great Britain and Ireland (ACPGBI)/United Kingdom Cancer Genetics Group (UKCGG). Gut 2020; 69: 411-444
• 4 Seppala TT, Latchford A, Negoi I. et al. European guidelines from the EHTG and ESCP for Lynch syndrome: an updated third edition of the Mallorca guidelines based on gene and gender. Br J Surg 2021; 108: 484-498
• 5 Gupta S, Provenzale D, Llor X. et al. NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 2.2019. J Natl Compr Canc Ne 2019; 17: 1032-1041
• 6 Haanstra JF, Dekker E, Cats A. et al. Effect of chromoendoscopy in the proximal colon on colorectal neoplasia detection in Lynch syndrome: a multicenter randomized controlled trial. Gastrointest Endosc 2019; 90: 624-632
• 7 Rivero-Sanchez L, Arnau-Collell C, Herrero J. et al. White-light endoscopy is adequate for Lynch Syndrome surveillance in a randomized and noninferiority study. Gastroenterology 2020; 158: 895-904 e891
• 8 Houwen B, Mostafavi N, Vleugels JLA. et al. Dye-based chromoendoscopy in patients with lynch syndrome: an individual patient data meta-analysis of randomized trials. Am J Gastroenterol 2021; 116: 825-828
• 9 Houwen B, Hazewinkel Y, Pellise M. et al. Linked colour imaging for the detection of polyps in patients with Lynch syndrome: a multicentre, parallel randomised controlled trial. Gut 2022; 71: 553-560
• 10 Abdeljawad K, Vemulapalli KC, Kahi CJ. et al. Sessile serrated polyp prevalence determined by a colonoscopist with a high lesion detection rate and an experienced pathologist. Gastrointest Endosc 2015; 81: 517-524
• 11 Rex DK, Sullivan AW, Perkins AJ. et al. Colorectal polyp prevalence and aspirational detection targets determined using high definition colonoscopy and a high level detector in 2017. Dig Liver Dis 2020; 52: 72-78
• 12 Rex DK, Repici A, Gross SA. et al. High-definition colonoscopy versus Endocuff versus EndoRings versus full-spectrum endoscopy for adenoma detection at colonoscopy: a multicenter randomized trial. Gastrointest Endosc 2018; 88: 335-344 e332
• 13 Vemulapalli KC, Rex DK. Risk of advanced lesions at first follow-up colonoscopy in high-risk groups as defined by the United Kingdom post-polypectomy surveillance guideline: data from a single U.S. center. Gastrointest Endosc 2014; 80: 299-306
• 14 Kahi CJ, Hewett DG, Norton DL. et al. Prevalence and variable detection of proximal colon serrated polyps during screening colonoscopy. Clin Gastroenterol Hepatol 2011; 9: 42-46
• 15 El Rahyel A, Vemulapalli KC, Lahr RE. et al. Implications of stable or increasing adenoma detection rate on the need for continuous measurement. Gastrointest Endosc 2022; 95: 948-953 e944
• 16 Kaminski MF, Regula J, Kraszewska E. et al. Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med 2010; 362: 1795-1803
• 17 Schottinger JE, Jensen CD, Ghai NR. et al. Association of physician adenoma detection rates with postcolonoscopy colorectal cancer. JAMA 2022; 327: 2114-2122
• 18 Rex DK. Colonoscopy: the current king of the hill in the USA. Dig Dis Sci 2015; 60: 639-646
• 19 Jarvinen HJ, Aarnio M, Mustonen H. et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 2000; 118: 829-834
• 20 de Jong AE, Hendriks YM, Kleibeuker JH. et al. Decrease in mortality in Lynch syndrome families because of surveillance. Gastroenterology 2006; 130: 665-671
• 21 Barrow P, Khan M, Lalloo F. et al. Systematic review of the impact of registration and screening on colorectal cancer incidence and mortality in familial adenomatous polyposis and Lynch syndrome. Br J Surg 2013; 100: 1719-1731